Je was op zoek naar: víetnam (IJslands - Engels)

víetnam
vietnam

a/víetnam
a/vietnam

víetnamska (víetnam)
vietnamese (vietnam)

a/víetnam/1203/2004 (h5n1)
a/vietnam/1203/2004 (h5n1)

Ónæmissvörun við a/víetnam/1194/2004
immune response to a/vietnam/1194/2004

Ónæmissvörun við a/víetnam/1194/2004 (h5n1):
immune response against a/vietnam/1194/2004 (h5n1):

Ónæmissvörun við a/víetnam/1194/2004 3-5 ára
immune response to a/vietnam/1194/2004 3-5 years

við a/víetnam 21 degi eftir örvun með a/víetnam
against a/vietnam 21 days after boosting with a/vietnam

a/víetnam/1203/2004 (h5n1) 7,5 míkrógrömm** í 0,5 ml skammti
a/vietnam/1203/2004 (h5n1) 7.5 microgram** per 0.5 ml dose

rannsóknir á eiturverkunum á æxlun hafa verið gerðar með notkun prepandrix sem innihélt a/víetnam/1194/2004
the reproductive toxicity studies have been conducted using prepandrix containing a/vietnam/1194/2004.

hlutfall mótefnasvörunar í marðardýrum bólusettum með 7,5 µg skammti af a/víetnam/1203/2004 bóluefninu var hátt.
ferrets vaccinated with the 7.5 µg dose of the a/vietnam/1203/2004 vaccine demonstrated a high rate of seroconversion.

hlutfall mótefnavarnar í marðardýrum bólusettum með 7,5 µg skammti af a/víetnam/1203/2004 bóluefninu var mjög hátt.
ferrets vaccinated with the 7.5 µg dose of the a/vietnam/1203/2004 vaccine demonstrated a high rate of seroconversion.

mótefnavaki a/víetnam/1194/2004 (h5n1)-líkur stofn notaður (nibrg-14)
antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14)

meirihluti þeirra 700 tilvika þar sem menn hafa sýkst frá árinu 1968 var upprunninn í suðaustur-asíu, þ.e. í kína, víetnam og norðurhluta tælands.
the majority of the 700 human cases which have been reported since 1968 originated from southeast asia, i.e. china, vietnam, and northern thailand.

sextán frettum var skipt í tvo hópa og voru þau bólusett á degi 0 og 21 með 7,5 µg af a/víetnam/1203/2004 bóluefni eða lyfleysubóluefni.
sixteen ferrets were divided into two cohorts and were vaccinated on days 0 and 21 with 7.5 µg of the a/vietnam/1203/2004 vaccine or were sham vaccinated.

a/víetnam/1194/2004 (h5n1)-líkur stofn (nibrg-14) 7,5 míkrógrömm hemagglútínín
a/vietnam/1194/2004 (h5n1)-like strain (nibrg-14) 7.5 micrograms haemagglutinin

krossónæmissvörun framkölluð af as03-ónæmisglæddu bóluefni, sem inniheldur 3,75 míkróg ha úr a/víetnam/1194/2004 (h5n1):
cross-reactive immune responses elicited by as03-adjuvanted vaccine containing 3.75 µg ha derived from a/vietnam/1194/2004 (h5n1):

a/víetnam/1194/2004 (h5n1)-líkur stofn notaður (nibrg-14) 3,75 míkrógrömm** í hverjum 0,5 ml skammti
a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) 3.75 micrograms** per 0.5 ml dose